| Date Filed | Type | Description |
| 03/10/2023 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $3.37, valued at
$33.7k
|
|
| 02/27/2023 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $3.98, valued at
$79.6k
|
|
| 02/09/2023 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 500,000 shares
@ $0
Granted 700,000 options to buy
@ $3.93, valued at
$2.8M
|
|
| 01/31/2023 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $4.05, valued at
$81k
|
|
| 01/24/2023 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $4.19, valued at
$83.8k
|
|
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $2.27, valued at
$34.1k
|
|
| 09/08/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $3.03, valued at
$45.5k
|
|
| 09/01/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $2.83, valued at
$42.5k
|
|
| 08/17/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $3.05, valued at
$45.8k
|
|
| 08/10/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $2.64, valued at
$39.6k
|
|
| 08/02/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $2.58, valued at
$38.7k
|
|
| 06/21/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $2.8, valued at
$56k
|
|
| 06/17/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $2.34, valued at
$46.8k
|
|
| 06/13/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $2.29, valued at
$68.7k
|
|
| 06/07/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $2.83, valued at
$84.9k
|
|
| 06/01/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $3.03, valued at
$60.6k
|
|
| 05/26/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $3.04, valued at
$60.8k
|
|
| 05/24/2022 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Bought 18,355 shares
@ $2.72, valued at
$49.9k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 600,000 shares
@ $0 |
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Schuetz Thomas J. (CEO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $5, valued at
$1.3M
|
|
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/15/2020 |
4
| Schuetz Thomas J. (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Unknown transaction of 89,695 shares
@ $60, valued at
$5.4M
Disposed/sold 18,086 options to buy
@ $0.7804, valued at
$14.1k
Disposed/sold 5,605 options to buy
@ $2.1852, valued at
$12.2k
Disposed/sold 9,000 options to buy
@ $15.03, valued at
$135.3k
Disposed/sold 9,000 options to buy
@ $0
Disposed/sold 10,000 options to buy
@ $38.65, valued at
$386.5k
Disposed/sold 16,200 options to buy
@ $24.74, valued at
$400.8k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2018 |
4
| Schuetz Thomas J. (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $38.65, valued at
$386.5k
|
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|